Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Initiating thymoregulator treatment]

J P Olié1, C Launay, M F Poirier

  • 1Service Hospitalo-Universitaire de Santé mentale et Thérapeutique, Centre hospitalier Sante-Anne, Paris.

L'Encephale
|March 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Addictive behaviors: Clinical facts].

Bulletin de l'Academie nationale de medecine·2020
Same author

Balneotherapy Together with a Psychoeducation Program for Benzodiazepine Withdrawal: A Feasibility Study.

Evidence-based complementary and alternative medicine : eCAM·2016
Same author

[Cognitive remediation therapy for children: literature data and clinical application in a child and adolescent psychiatry department].

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie·2015
Same author

Modulation of energy and protein supplies in sequential feeding in laying hens.

Animal : an international journal of animal bioscience·2014
Same author

[Controlled drug consumption rooms].

Bulletin de l'Academie nationale de medecine·2014
Same author

Do not resuscitate orders and aging: impact of multimorbidity on the decision-making process.

The journal of nutrition, health & aging·2014
Same journal

Measuring antidepressant side effects in military personnel - Clinical validation of the French version of the UKU-SERS-Pat Scale: A comparative study of patient and clinician ratings.

L'Encephale·2026
Same journal

[Empowerment in addictology].

L'Encephale·2026
Same journal

Evaluation of the links between smoking and conspiracy mentality.

L'Encephale·2026
Same journal

Use of a relevance assessment tool in therapeutic residential care: A real world study.

L'Encephale·2026
Same journal

Prevalence and characteristics of domestic violence in a sample of adult psychiatric outpatients: A cross-sectional study.

L'Encephale·2026
Same journal

From representations to practice: how professionals describe supporting parents with psychiatric or somatic illness or disability.

L'Encephale·2026
See all related articles

Lithium therapy is recommended for recurrent affective disorders, demonstrating significant efficacy in preventing episodes compared to placebo. However, about one-third of bipolar patients do not respond to lithium treatment.

Area of Science:

  • Psychiatry
  • Pharmacology

Context:

  • Recurrent affective disorders, including bipolar disorder, necessitate effective long-term management strategies.
  • Lithium has been a cornerstone treatment for bipolar disorder, but its efficacy and optimal administration require ongoing investigation.

Purpose:

  • To review the established criteria for initiating lithium therapy in recurrent affective disorders.
  • To evaluate the prophylactic efficacy of lithium salts based on placebo-controlled studies.
  • To address current questions regarding lithium therapy, including patient response and dosing strategies.

Summary:

  • Initiating lithium therapy is justified by specific recurrence patterns of affective episodes, such as two acute episodes within five years or an acute manic episode.
  • Placebo-controlled studies confirm lithium's prophylactic efficacy, significantly reducing recurrence rates from 38-93% with placebo to 0-44% with lithium.

Related Experiment Videos

  • Approximately one-third of bipolar patients exhibit non-response to lithium, with outcomes varying based on selection criteria and study duration.

    • Impact:

    • Provides evidence-based guidelines for initiating lithium treatment in patients with recurrent affective disorders.
    • Highlights the significant impact of lithium in reducing mood episode recurrence in bipolar disorder.
    • Identifies the challenge of lithium non-response in a subset of bipolar patients, prompting further research into treatment optimization.